Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering

Trends in Biotechnology

Volumn 27, Issue 10, 2009, Pages 562-571

  Grellier, M ^a   Bordenave, L ^a,b   Amedee J ^a  

^a INSERM   (France)

^b Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BONE REGENERATION; BONE TISSUE; BONE TISSUE ENGINEERING; BONE-FORMING CELLS; CELL COUPLING; CELL TYPES; CELL-TO-CELL COMMUNICATION; MESENCHYMAL STEM CELL; NEW STRATEGY; OSTEOGENIC; PARACRINE; RESEARCH EFFORTS; TUBE FORMATION; VASCULARIZATION;

BLOOD VESSEL PROSTHESES; BONE; CELL CULTURE; CELL MEMBRANES; SCAFFOLDS; SELF ASSEMBLY; TISSUE ENGINEERING;

ENDOTHELIAL CELLS;

TISSUE SCAFFOLD;

ANGIOGENESIS; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE GRAFT; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINEAGE; COCULTURE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GAP JUNCTION; HUMAN; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; NONHUMAN; OSTEOBLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; VASCULARIZATION;

CELL COMMUNICATION; ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCYTES; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 69949089188     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2009.07.001     Document Type: Review

References (70)

1. Towler D.A. The osteogenic-angiogenic interface: novel insights into the biology of bone formation and fracture repair. Curr Osteoporos Rep 6 (2008) 67-71
2. Moon J.J., and West J.L. Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr Top Med Chem 8 (2008) 300-310
3. Pelissier P., et al. Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats. Plast Reconstr Surg 111 (2003) 1932-1941
4. Smith M.K., et al. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng 10 (2004) 63-71
5. Rouwkema J., et al. Vascularization in tissue engineering. Trends Biotechnol 26 (2008) 434-441
6. Yang S., et al. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 7 (2001) 679-689
7. Kaigler D., et al. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21 (2006) 735-744
8. Unger R.E., et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 28 (2007) 3965-3976
9. Rouwkema J., et al. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12 (2006) 2685-2693
10. Krenning G., et al. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 15 4 (2009) 180-189
11. Rivron N.C., et al. Engineering vascularised tissues in vitro. Eur Cell Mater 15 (2008) 27-40
12. Villars F., et al. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?. J Cell Biochem 79 (2000) 672-685
13. Guillotin B., et al. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 42 (2008) 1080-1091
14. Grellier M., et al. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J Cell Biochem 106 (2009) 390-398
15. Clarkin C.E., et al. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 214 (2008) 537-544
16. Wenger A., et al. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng 10 (2004) 1536-1547
17. Stahl A., et al. Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts. FEBS Lett 579 (2005) 5338-5342
18. Steffens L., et al. In vivo engineering of a human vasculature for bone tissue engineering applications. J Cell Mol Med 28 (2008)
19. Kaigler D., et al. Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res 85 (2006) 633-637
20. Fuchs S., et al. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 13 (2007) 2577-2588
21. Fuchs S., et al. Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 30 (2009) 1329-1338
22. Meury T., et al. Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression. J Cell Biochem 98 (2006) 992-1006
23. Jarrahy R., et al. Osteogenic differentiation is inhibited and angiogenic expression is enhanced in MC3T3-E1 cells cultured on three-dimensional scaffolds. Am J Physiol Cell Physiol 289 (2005) C408-414
24. Kaigler D., et al. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. Faseb J 19 (2005) 665-667
25. Grellier M., et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30 19 (2009) 3271-3278
26. Sun H., et al. In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds. Biomed Eng Online 6 (2007) 41
27. Hofmann A., et al. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 29 (2008) 4217-4226
28. Fuchs S., et al. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 30 (2009) 526-534
29. Guillotin B., et al. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. Cell Physiol Biochem 14 (2004) 325-332
30. Villars F., et al. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 282 (2002) C775-785
31. Rouwkema J., et al. The Use of Endothelial Progenitor Cells for Prevascularized Bone Tissue Engineering. Tissue Eng Part A 12 (2009)
32. Bouletreau P.J., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109 (2002) 2384-2397
33. Wang D.S., et al. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138 (1997) 2953-2962
34. Yu H., et al. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials 30 (2009) 508-517
35. Stahl A., et al. Bi-directional cell contact-dependent regulation of gene expression between endothelial cells and osteoblasts in a three-dimensional spheroidal coculture model. Biochem Biophys Res Commun 322 (2004) 684-692
36. Veillette C.J., and von Schroeder H.P. Endothelin-1 down-regulates the expression of vascular endothelial growth factor-A associated with osteoprogenitor proliferation and differentiation. Bone 34 (2004) 288-296
37. Fiedler J., et al. IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun 345 (2006) 1177-1183
38. Clarkin C.E., et al. Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: A negative modulatory role for prostanoids in VEGF-mediated cell: cell communication?. Exp Cell Res 314 (2008) 3152-3161
39. Carano R.A., and Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 8 (2003) 980-989
40. Street J., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99 (2002) 9656-9661
41. Zelzer E., et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129 (2002) 1893-1904
42. Spector J.A., et al. Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am J Physiol Cell Physiol 280 (2001) C72-80
43. Mayer H., et al. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95 (2005) 827-839
44. Deckers M.M., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 (2002) 1545-1553
45. Mayr-Wohlfart U., et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30 (2002) 472-477
46. Keramaris N.C., et al. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury 39 Suppl 2 (2008) S45-57
47. Fiedler J., et al. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334 (2005) 561-568
48. Wan C., et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105 (2008) 686-691
49. Distler J.H., et al. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47 (2003) 149-161
50. Marie P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316 (2003) 23-32
51. Tokuda H., et al. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J Bone Miner Res 15 (2000) 2371-2379
52. Kanaan R.A., et al. The role of connective tissue growth factor in skeletal growth and development. Med Sci Monit 12 (2006) RA277-281
53. Lebrin F., et al. TGF-beta receptor function in the endothelium. Cardiovasc Res 65 (2005) 599-608
54. Lagumdzija A., et al. Inhibited anabolic effect of insulin-like growth factor-I on stromal bone marrow cells in endothelial nitric oxide synthase-knockout mice. Acta Physiol Scand 182 (2004) 29-35
55. Qu G., and von Schroeder H.P. Role of osterix in endothelin-1-induced downregulation of vascular endothelial growth factor in osteoblastic cells. Bone 38 (2006) 21-29
56. Niger C., et al. Endothelin-1 inhibits human osteoblastic cell differentiation: influence of connexin-43 expression level. J Cell Biochem 103 (2008) 110-122
57. Gennero I., et al. [Bone mineral metabolism: recent data and perspectives related to osteogenesis]. Arch Pediatr 11 (2004) 1473-1483
58. Schmidt C.E., and Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21 (2000) 2215-2231
59. Ott H.C., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14 (2008) 213-221
60. Dbouk H.A., et al. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 7 (2009) 4
61. Stains J.P., and Civitelli R. Gap junctions in skeletal development and function. Biochim Biophys Acta 1719 (2005) 69-81
62. Yeh H.I., et al. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am J Hypertens 19 (2006) 129-135
63. Stains J.P., and Civitelli R. Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol Biol Cell 16 (2005) 64-72
64. Negroiu G., et al. Biocompatibility evaluation of a novel hydroxyapatite-polymer coating for medical implants (in vitro tests). J Mater Sci Mater Med 19 (2008) 1537-1544
65. Granja P.L., et al. Mineralization of regenerated cellulose hydrogels induced by human bone marrow stromal cells. Eur Cell Mater 10 (2005) 31-37 discussion 37-39
66. Schmidmaier G., et al. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury 38 Suppl 4 (2007) S35-S41
67. Friedlaender G.E., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1 (2001) S151-158
68. Simmons C.A., et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35 (2004) 562-569
69. Titorencu I., et al. Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells. Cytotherapy 9 (2007) 682-696
70. Vilamitjana-Amedee J., et al. Human bone marrow stromal cells express an osteoblastic phenotype in culture. In Vitro Cell Dev Biol Anim 29A (1993) 699-707